1、医疗卫生领域腐败整治的执法动态与监管重点 Law enforcement dynamics and regulatory priorities in medical industry

纪检监察机关办案流程及调查手段 The process of handling cases by disciplinary organs and investigation techniques

联合稽查会查哪些事项？监管重点是哪些？ What matters are investigated? What are the regulatory priorities?

当前稽查执法成果及未来趋势 Law enforcement outcomes and future trends

2、药械企业业务流程的合规审查与建议 Compliance review and recommendations for business processes in pharmaceutical industry

药械经销协议、经销业务、销售激励的合规建议 Distribution agreements and compliance suggestions

学术推广风险：微信建群、网络会议、第三方医学平台、医药自建平台 Academic promotion sub-risks

讲课费的合规风险 Lecture fees compliance risks

设备投放、医疗赞助的合规管理 Compliance risks of equipment placement, medical sponsorships

医疗企业、经销商、医药代表的“带金销售”向“学术专业导向” 的转变 “Sale with Gold” to “Professional Orientation”

药械企业回款难的现状：虚开发票与税务稽查 Fraudulent invoicing and tax audits

3、医疗企业如何应对行业集中反腐执法及刑事风险救济路径 Respond to Industry-Centralized anti-corruption enforcement and remediation paths

企业的自纠自查 Self-correction and self-inspection

面对突袭调查时企业的处理原则 Processing principles when faced with unannounced investigations

企业配合调查时如何保护自身合法权益 How to protect company’s legitimate rights？

企业行贿面临的法律责任 Legal liability for corporate bribery

刑事合规不起诉现实探讨 Criminal Compliance Non-Prosecution System

ACI通过北京、上海2场闭门会议，大家畅所欲言，互通有无，落地实践的干货让与会各位受益匪浅。